Anika Therapeutics
-
Biologics
Anika Names Cheryl R. Blanchard, Ph.D., as President and Chief Executive Officer
April 27, 2020 BEDFORD, Mass.–(BUSINESS WIRE)–Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated joint preservation and regenerative therapies company with products…
Read More » -
Biologics
Anika Appoints David Colleran as General Counsel
March 04, 2020 BEDFORD, Mass.–(BUSINESS WIRE)–Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated joint preservation and regenerative therapies company with products…
Read More » -
Financial
Anika Therapeutics Closes Acquisition of Arthrosurface
BEDFORD, Mass., Feb. 03, 2020 (GLOBE NEWSWIRE) — Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated joint preservation and regenerative therapies company…
Read More » -
Extremities
Anika Commences Full U.S. Commercial Launch of TACTOSET Bone Repair Therapy at Orthopaedic Summit 2019: Evolving Techniques
December 10, 2019 BEDFORD, Mass.–(BUSINESS WIRE)–Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated joint preservation and regenerative therapies company with products…
Read More » -
Biologics
Anika Appoints Mira Leiwant as Vice President of Regulatory Affairs, Quality, and Clinical Affairs
October 14, 2019 BEDFORD, Mass.–(BUSINESS WIRE)–Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated company, focused on developing regenerative therapies leveraging its…
Read More » -
Biologics
Anika Announces Successful Completion of First Human Surgical Procedure with Injectable HA-Based Bone Repair Therapy
August 13, 2019 BEDFORD, Mass.–(BUSINESS WIRE)–Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedic and regenerative medicines company specializing in therapeutics…
Read More » -
Financial
Anika Reports Second Quarter 2019 Financial Results
July 24, 2019 BEDFORD, Mass.–(BUSINESS WIRE)–Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedic and regenerative medicines company specializing in therapeutics…
Read More » -
Biologics
Anika Appoints James Loerop as Executive Vice President of Business Development and Strategic Planning
July 08, 2019 BEDFORD, Mass.–(BUSINESS WIRE)–Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedic and regenerative medicines company specializing in therapeutics…
Read More » -
Financial
Anika Reports First Quarter 2019 Financial Results
May 02, 2019 BEDFORD, Mass.–(BUSINESS WIRE)–Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedic and regenerative medicines company specializing in therapeutics…
Read More » -
Biologics
Anika Appoints Stephen Goldy as Vice President of U.S. Sales
April 30, 2019 BEDFORD, Mass.–(BUSINESS WIRE)–Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedic and regenerative medicines company specializing in therapeutics…
Read More » -
Biologics
Anika Appoints Robert Richard, Ph.D. as Vice President of Research and Development
March 18, 2019 BEDFORD, Mass.–(BUSINESS WIRE)–Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedic and regenerative medicines company specializing in therapeutics…
Read More » -
Biologics
Anika to Showcase Commercial and Pipeline Portfolio at 2019 AAOS Annual Meeting
March 11, 2019 BEDFORD, Mass.–(BUSINESS WIRE)–Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedics and regenerative medicines company specializing in therapeutics…
Read More » -
Financial
Anika Reports Fourth Quarter and Full Year 2018 Financial Results
February 21, 2019 BEDFORD, Mass.–(BUSINESS WIRE)–Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedic and regenerative medicines company specializing in therapeutics…
Read More » -
Biologics
Anika Announces Plans to Showcase HYALOFAST at the International Cartilage Regeneration and Joint Preservation Society (ICRS) Summit in San Diego
January 16, 2019 BEDFORD, Mass.–(BUSINESS WIRE)–Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedic and regenerative medicines company specializing in therapeutics…
Read More »